Home » Topics » BioWorld Science

BioWorld Science
RSS

Refuge Biotechnologies completes series B financing

May 4, 2018

FDA grants orphan drug designation to BN-Brachyury as treatment for chordoma

May 4, 2018

FDA advisory committee votes to recommend Siga's Tpoxx smallpox treatment

May 3, 2018

Heptares Therapeutics divulges novel M1 and/or M4 receptor agonists

May 3, 2018

Novel mutant IDH inhibitors presented by Isocure Biosciences

May 3, 2018

TES Pharma discovers ACMSD inhibitors

May 3, 2018

Mission Therapeutics patents USP30 inhibitors

May 3, 2018

Araxes Pharma presents new mutant RAS inhibitors

May 3, 2018

FDA issues complete response letter for Sandoz rituximab biosimilar

May 3, 2018

BIIB-092 shows safe pharmacodynamic activity in progressive supranuclear palsy trial

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...